Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 324,524 |
|
|||||
| News | - | ||||||
| Day High | 0.855499 | Low High |
|||||
| Day Low | 0.72 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| MIRA Pharmaceuticals Inc | MIRA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0679 | -8.40% | 0.74 | 18:17:22 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.80 | 0.72 | 0.855499 | 0.733 | 0.8079 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 598 | 324,524 | US$ 0.7567146 | US$ 245,572 | - | 0.72 - 7.9799 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:28:08 | 1 | US$ 0.7467 | USD |
MIRA Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 10.79M | 14.78M | - | 0 | -11.98M | -0.81 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MIRA Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/02/2024 | 07:00 | PR Newswire (US) | Mira Pharmaceuticals Announces Encouraging Preclinical.. |
| 3/21/2024 | 10:04 | PR Newswire (US) | MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head.. |
| 3/07/2024 | 15:45 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/05/2024 | 07:30 | PR Newswire (US) | MIRA Pharmaceuticals Provides Corporate Update |
| 1/17/2024 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/27/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 12/27/2023 | 16:33 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/27/2023 | 16:27 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of.. |
| 12/18/2023 | 15:50 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
| 12/04/2023 | 07:00 | PR Newswire (US) | MIRA Pharmaceuticals Releases Breakthrough Data from.. |
| 12/01/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/29/2023 | 07:00 | PR Newswire (US) | MIRA Pharmaceuticals Announces Ketamir-2's Oral.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MIRA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.9171 | 0.9171 | 0.72 | 0.8327246 | 17,903 | -0.1771 | -19.31% |
| 1 Month | 1.02 | 1.06 | 0.72 | 0.8936652 | 35,960 | -0.28 | -27.45% |
| 3 Months | 1.00 | 1.84 | 0.72 | 1.49 | 626,943 | -0.26 | -26.00% |
| 6 Months | 1.57 | 6.40 | 0.72 | 1.79 | 464,540 | -0.83 | -52.87% |
| 1 Year | 7.00 | 7.9799 | 0.72 | 2.11 | 336,933 | -6.26 | -89.43% |
| 3 Years | 7.00 | 7.9799 | 0.72 | 2.11 | 336,933 | -6.26 | -89.43% |
| 5 Years | 7.00 | 7.9799 | 0.72 | 2.11 | 336,933 | -6.26 | -89.43% |
MIRA Pharmaceuticals Description
| MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. |
